Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...
Nisha Kumar Behringer ’91 said she would push Harvard to more forcefully defend its public value — and rethink its relationship with Washington — if elected to the Board of Overseers this spring, as ...
WOIPPY, France, February 19, 2026--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics S.A. (Euronext: ABLD – ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into ...
Just a few weeks after unveiling its clone of the Lovetone Meatball envelope filter pedal, Behringer is plundering the boutique pedal manufacturer's vaults once again with a recreation of the Ring ...
Just weeks after showcasing it at NAMM 2026, Behringer has announced the official release of the JN-80, an eight-voice Roland Juno-60 clone that the German manufacturer first teased us with all the ...
In early trading on the 30th, ABL Bio is plunging more than 14%. The drop is seen as a reaction to news that a Parkinson's disease drug candidate it licensed to Sanofi has been pushed down the ...
ABL Bio said on the 19th that the U.S. Food and Drug Administration (FDA) approved the phase 1 investigational new drug (IND) application for its bispecific Antibody-Drug Conjugate (ADC) candidate ...
SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...
Energy and marine consultancy ABL has secured new five-year contracts with long-term client Woodside Energy that expands its existing workscope outside of Australia. ABL has been awarded a global ...
Eli Lilly has signed an agreement with ABL Biotech for access to the South Korean biotech's Grabody platform to develop bispecific antibodies that is worth up to $2.6B. Deal terms call for ABL Bio to ...
South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results